Search

everythinglearnresearchcommunity

for

Search:↓

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Women with female pattern hair loss have lower Vitamin D3 levels.

Combination therapy improves hair growth in advanced hair loss.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Cutaneous gene therapy could become a viable treatment for skin and hair disorders with improved vector development and gene expression control.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Women with androgenetic alopecia have lower zinc and iron levels.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.

Embryonic and adult stem cells are valuable for improving skin grafts and cell therapy.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.